TRACON Pharmaceuticals Inc is a clinical stage biopharmaceutical company. The Company is engaged in the development and commercialization of novel targeted therapeutics for cancer, age-related macular degeneration and fibrotic diseases.
| Website: | www.traconpharma.com |
| Main Phone: | +1 858 550-0780 |
| Address: | 8910 University Center Lane |
| Address 2: | Suite 700 |
| State: | CA |
| City / Town: | San Diego |
| Country: | USA |
| Postal Code: | 92122 |
| Exchange: | NSD |
| Employees: | 23 |
| NAICS: | Medicinal and Bo |
| Last Price 2.23 | Change $ -0.025 | Change % -1.11 | Tick N/A |
| Bid N/A | Bid Size 0.00 | Ask 16.00 | Ask Size 200.00 |
| Open 2.30 | High 2.30 | Low 2.20 | Prev Close 2.25 |
| Last Trade | Volume 37,947 | 52 Wk Hi 7.30 | 52 Wk Low 2.00 |
| Market Cap 37 mi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 16,609,055.00 | EPS (TTM) -2.03 | PE Ratio N/A | Exchange NSD |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 6 | 14 |
| Number of Buys | 5 | 10 |
| Number of Sells | 1 | 4 |
| Net Activity | 36497 | 188781 |
| Last 10 Buys | Shares |
|---|---|
| M. James Barrett | 1,000 |
| Peter J. Barris | 1,000 |
| Forest Baskett | 1,000 |
| Ryan D. Drant | 1,000 |
| Anthony A. Florence | 1,000 |
| Patrick J. Kerins | 1,000 |
| Krishna Kolluri | 1,000 |
| David M. Mott | 1,000 |
| Sandell D Scott | 1,000 |
| Ravi Viswanathan | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| Ronald L. Shazer | 1,000 |
| Charles P. Theuer | 1,000 |
| H Casey Logan | 1,000 |
| Charles P. Theuer | 1,000 |
| Charles P. Theuer | 1,000 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 14 | 14 | 14 | 14 |
| Low Target Price Estimate | 14 | 14 | 14 | 14 |
| Mean Target Price Estimate | 14 | 14 | 14 | 14 |
| Standard Deviation | 0 | 0 | 0 | 0 |
| Date of Most Recent Estimate | 08/10/16 | 06/06/16 | 06/06/16 | 08/10/16 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 10-Q | Quarterly report with a continuing view of a company's financial position | 61 | 2016-08-11 |
| 8-K | Report of unscheduled material events or corporate changes. | 10 | 2016-08-10 |
| 8-K | Report of unscheduled material events or corporate changes. | 3 | 2016-07-29 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-06-07 |
| 8-K | Report of unscheduled material events or corporate changes. | 10 | 2016-06-07 |
| 8-K | Report of unscheduled material events or corporate changes. | 3 | 2016-06-03 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-06-02 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-06-02 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-06-02 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-06-02 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 2 | 2 | 3 | 3 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 1 | 1 | 1 | 1 |
© 2017 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
